- The endoscopic AI differentiates gastric lesions as neoplastic or non-neoplastic -TOKYO (BUSINESS WIRE) AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce the first instance of Singaporean regulatory review and device.
TOKYO, October 12, 2023 AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of Gastroenterology and Hepatology (hereinafter IGH) and will begin research activities on October 27, 2023. AIM is the first Japanese company to sign a joint research agreement with IGH in the field of endoscopic AI, and IGH is the first Vietnamese institute that AIM has collaborated with thus far